SCHEMBL5522293

SCHEMBL5522293

CN1C(=Cc2c(O)c(=O)c2=NO)C(C)(C)c2ccccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.52
LMNA P02545 10/20 0.49
HTT P42858 6/20 0.49
KDM4E B2RXH2 7/20 0.47
HSD17B10 Q99714 2/20 0.47
MAPK1 P28482 2/20 0.47
ALOX15 P16050 1/20 0.47
ALDH1A1 P00352 3/20 0.46
TSHR P16473 2/20 0.46
CASP1 P29466 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MEN1 O00255 7/20 0.45
KMT2A Q03164 7/20 0.45
USP2 O75604 2/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
POLB P06746 2/20 0.45
GAA P10253 4/20 0.44
THRB P10828 2/20 0.44
RECQL P46063 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14453270 1.00 MAPT (0.52) MAPTLMNAHTTKDM4EHSD17B10
SCHEMBL14093791 0.86 MAPT (0.48) MAPTLMNAHTTKDM4EHSD17B10
SCHEMBL3853022 0.86 LMNA (0.55) MAPTLMNAHTTKDM4EHSD17B10
SCHEMBL3853014 0.86 LMNA (0.55) MAPTLMNAHTTKDM4EHSD17B10
SCHEMBL5517797 0.80 MEN1 (0.43) MAPTLMNAHTTKDM4EHSD17B10
SCHEMBL14093786 0.76 LMNA (0.55) MAPTLMNAHTTKDM4EHSD17B10
SCHEMBL17627872 0.74 LMNA (0.54) MAPTLMNAHTTKDM4EHSD17B10
SCHEMBL7701823 0.73 LMNA (0.52) MAPTLMNAHTTKDM4EHSD17B10
SCHEMBL7701821 0.73 LMNA (0.52) MAPTLMNAHTTKDM4EHSD17B10
SCHEMBL14075928 0.73 HTT (0.58) MAPTLMNAHTTKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250517-B2 Luminescent compounds Terpetschnig, Ewald A. (US) 2007-07-31 US disclosed
US-20040166515-A1 Luminescent compounds TERPETSCHNIG, EWALD A. 2004-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040166515-A1 Luminescent compounds RORC, NR2E3, RORB MAPT 4542/4885LMNA 1196/4885HTT 3369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.